24-Jun-2014 - Bayer CropScience AG

David Nicholson to leave Bayer CropScience

Adrian Percy announced as New Head of Research and Development

Effective August 1, 2014 Dr. Adrian Percy, currently Senior Vice President of Global Regulatory Affairs within Bayer CropScience will take over the position as Global Head of Research & Development (R&D). In his new role, Dr. Percy will also become member of the Bayer CropScience Excecutive Committee. Currently Adrian Percy (49) has responsibility for regulatory activities across the Bayer CropScience technology platforms, including Seeds & Traits, Crop Protection and Environmental Science globally. He began his career in 1991 as a Toxicologist with Rhone-Poulenc in France. Since then, he has held numerous positions in the Research and Development departments of Bayer CropScience and its legacy companies in France, Germany and the USA.

Adrian Percy grew up and studied in the United Kingdom earning a Bachelor’s degree in Pharmacology at the University of Liverpool, a Master’s degree in Toxicology and then a doctorate in Biochemistry at the University of Birmingham. Adrian is married, has two children and currently resides in Raleigh, North Carolina, USA.

Dr. David Nicholson, currently Head of R&D has decided to leave the company to pursue other career opportunities outside of Bayer, effective July 31, 2014. “We thank Dr. Nicholson for his valuable contributions to the company and wish him all the best for the future”, says Bayer CropScience CEO Liam Condon.

Facts, background information, dossiers
  • Bayer
More about Bayer CropScience
More about Bayer
  • News

    Bayer delivers robust performance despite pandemic

    The Bayer Group delivered robust operational performance in 2020. “Our operational strength in these turbulent times shows just how resilient our businesses are, even during the pandemic,” said Werner Baumann, Chairman of the Board of Management, on Thursday during the company’s Financial N ... more

    Bayer: Challenging third quarter

    Bayer has confirmed its targets for full-year 2020 following a challenging third quarter due to seasonal factors. “Despite the weak quarter and the substantial impact of the pandemic, our currency- and portfolio-adjusted sales and core earnings per share in the first nine months of the year ... more

    Bayer: Supervisory Board extends CEO Werner Baumann’s

    The Supervisory Board of Bayer AG has unanimously decided to extend the contract of Werner Baumann, Chairman of the Board of Management, until April 30, 2024. Before the extension, Baumann’s contract would have expired at the 2021 Annual Stockholders’ Meeting. Baumann, 57, has worked for Ba ... more

  • Companies

    Bayer S.A./NV.

    Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more

    Bayer Corporation

    Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more

    Bayer Industriepark Brunsbüttel

    more